Pia Wallmeier, Sabrina Arnold, Arlette Tais, Gabriele Ihorst, Marco Janoschke, Fabian Schubach, Peer Aries, Raoul Bergner, Jan Phillip Bremer, Norman Görl, Eva Gutdeutsch, Bernhard Hellmich, Jörg Henes, Bimba Franziska Hoyer, Antje Kangowski, Ina Kötter, Martin Krusche, Tim Magnus, Claudia Metzler, Ulf Müller-Ladner, Matthias Schaier, Ulf Schönermarck, Jens Thiel, Leonore Unger, Nils Venhoff, Julia Weinmann-Menke, Jana Petersen, Peter Lamprecht, Christof Iking-Konert
OBJECTIVES: Giant cell arteritis (GCA) is one of the most common forms of vasculitis. There is an abundance of studies which are conducted in a randomised controlled trial setting but limited with respect to cohort size and follow-up time. GeVas is the first large-scale registry for vasculitides in German-speaking countries that enables to evaluate this rare disease. Herein we focus on the subgroup of GCA patients including follow-up data up to one year. METHODS: GeVas is a prospective, web-based, multicentre registry for the documentation of organ manifestations, outcomes, and therapy regimens in vasculitides...
April 2024: Clinical and Experimental Rheumatology